Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$231K Buy
657
+29
+5% +$10.3K 0.09% 94
2025
Q4
$206K Sell
628
-148
-19% -$46.9K 0.09% 103
2025
Q3
$219K Sell
776
-1
-0.1% -$290 0.12% 94
2025
Q2
$217K Sell
777
-127
-14% -$36K 0.13% 94
2025
Q1
$282K Sell
904
-64
-7% -$18.9K 0.19% 79
2024
Q4
$252K Sell
968
-9
-0.9% -$2.67K 0.17% 90
2024
Q3
$315K Buy
977
+87
+10% +$28.5K 0.21% 72
2024
Q2
$278K Sell
890
-45
-5% -$13.2K 0.21% 79
2024
Q1
$266K Sell
935
-33
-3% -$9.66K 0.2% 77
2023
Q4
$279K Sell
968
-75
-7% -$20.4K 0.22% 76
2023
Q3
$280K Buy
+1,043
New +$260K 0.29% 70
2023
Q1
$266K Buy
+935
New +$230K 0.2% 77

Other funds holding AMGN

Fidelity D&D Bancorp's AMGN Position: Q1 2026 in Review

Fidelity D&D Bancorp increased its Amgen (AMGN) stake by 4.6% in Q1 2026, buying an estimated $10.3K and bringing the position to 657 shares worth $231K. The position accounts for 0.09% of the portfolio, ranked #94.

Fidelity D&D Bancorp first reported a position in AMGN in Q1 2023 and has held it in 12 quarters since. The position peaked at $315K in Q3 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Fidelity D&D Bancorp held 657 shares of Amgen worth $231K as of Q1 2026.
  • Fidelity D&D Bancorp bought 29 Amgen shares in Q1 2026, an estimated $10.3K.
  • Amgen made up 0.09% of Fidelity D&D Bancorp's portfolio in Q1 2026, its #94 holding.
  • Fidelity D&D Bancorp first reported a position in Amgen in Q1 2023 and has held it in 12 quarters since.
  • Fidelity D&D Bancorp's Amgen position peaked at $315K in Q3 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Fidelity D&D Bancorp's 13F filing for Q1 2026, filed 30 Apr 2026.